Drilling Down Into The Trade Desk, Inc. (TTD)

The Trade Desk, Inc. (TTD) is an interesting player in the Technology space, with a focus on Application Software. The stock has been active on the tape, currently trading at $52.73, up from yesterday’s close by 2.35%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

The Trade Desk, Inc. (TTD) currently trades with a market capitalization of $2.21 Billion. That value represents a market adjusting for revenues that have been growing by 41.76 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $21.11 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.1 on a per share basis this quarter. Perhaps, that suggests something about why 1.39% of the outstanding share supply is held by institutional investors.



Technical Analysis

It’s important to check the technicals to get a sense of how TTD has been acting. Looking at the stock’s movement on the chart, The Trade Desk, Inc. recorded a 52-week high of $67.30. It is now trading 14.57% off that level. The stock is trading $53.16 its 50-day moving average by 0.43%. The stock carved out a 52-week low down at $39.25.

In recent action, The Trade Desk, Inc. (TTD) has made a move of +1.23% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.84, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 28.02% with $31.04 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of TTD.

SHARE
Previous articleCelldex Therapeutics, Inc. (CLDX): From Top to Bottom
Next articleThe Case for and Against 3M Company (MMM)